Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis.
about
Characterization of IgG glycosylation in rheumatoid arthritis patients by MALDI-TOF-MSn and capillary electrophoresis.Estrogens regulate glycosylation of IgG in women and menBasement membranes and autoimmune diseases.Immunoglobulin Glycosylation Effects in Allergy and Immunity.High-throughput characterization of the functional impact of IgG Fc glycan aberrancy in juvenile idiopathic arthritis.Engineered Sialylation of Pathogenic Antibodies In Vivo Attenuates Autoimmune Disease.Recombinant Proteins and Monoclonal Antibodies.Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity?Fcγ Receptor Function and the Design of Vaccination Strategies.Increased Polysialylation of the Neural Cell Adhesion Molecule in a Transgenic Mouse Model of Sialuria.Sweet SIGNs: IgG glycosylation leads the way in IVIG-mediated resolution of inflammation.Defining the proteomic landscape of rheumatoid arthritis: progress and prospective clinical applications.The role of anti-citrullinated protein antibodies (ACPA) in the pathogenesis of rheumatoid arthritis.Targeting IgG in Arthritis: Disease Pathways and Therapeutic Avenues.Novel Concepts of Altered Immunoglobulin G Galactosylation in Autoimmune Diseases.Diversification of IgG effector functions.Potential of Murine IgG1 and Human IgG4 to Inhibit the Classical Complement and Fcγ Receptor Activation Pathways.Sialylated Autoantigen-Reactive IgG Antibodies Attenuate Disease Development in Autoimmune Mouse Models of Lupus Nephritis and Rheumatoid Arthritis.Estrogen induces St6gal1 expression and increases IgG sialylation in mice and patients with rheumatoid arthritis: a potential explanation for the increased risk of rheumatoid arthritis in postmenopausal women.Tertiary Lymphoid Structures: Autoimmunity Goes Local
P2860
Q36342795-2604684B-98F0-4715-860B-AF994182BB30Q37646832-ACED1FCB-FAC6-46BC-BC04-2A33E1C9A9EEQ38920115-3CE1DF55-8231-4191-A6C7-FAFAD6DD3B6AQ38994739-7532E3D9-BE8D-4ACA-8B88-148D917F8A18Q45945255-E5A0B9F3-5B11-428A-B885-F12D9863DB1FQ47220975-BFDD8055-BADB-4EBF-8A0E-F110D607D733Q47602370-F5D9C730-573A-4330-8561-CA4BAC773F0BQ47804590-99DB74A3-A460-4195-A330-AB577F83A35CQ47945550-57D20B13-E18A-421D-91A2-ADCA6386FAFBQ48396096-B9D1A539-D05C-4CCD-ACAE-A131ADF0A145Q50193260-06EDA54B-19A3-46D8-A298-C15D941AFD37Q50210105-C5FBA158-6F85-410A-81C3-35F4FBD9911EQ50308665-2E905B94-0387-40B9-A10B-D4E86611FC06Q52370705-7EC09B48-0598-4E6F-9F8C-67B1D8B079A0Q52608527-0FD2F3BE-20CB-4060-BEEE-C5E968ECC518Q53313488-A3739241-39BD-4C8E-B6C7-873594535DD4Q55250588-4E5709EB-6943-4A54-A839-2A5DBE4C83BCQ55347406-C2591DB2-5222-49C9-9C43-20E4C86C1C86Q55395226-0752678A-70B2-4756-AC94-148188015187Q58746430-A96E503B-C910-40D1-8251-593850A8F8E1
P2860
Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis.
@ast
Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis.
@en
type
label
Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis.
@ast
Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis.
@en
prefLabel
Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis.
@ast
Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis.
@en
P2093
P2860
P356
P1476
Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis
@en
P2093
Akira Harazono
Atsushi Kumanogoh
Daisuke Takakura
Fumihiro Sugiyama
Hirofumi Shoda
Kazuhiko Yamamoto
Keishi Fujio
Koichi Furukawa
Nana Kawasaki
Nobunori Takahashi
P2860
P2888
P356
10.1038/NCOMMS11205
P407
P577
2016-04-05T00:00:00Z